Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Mila Lebedeva"'
Autor:
James C. Zimring, Walter Bialkowski, Nelly Gefter, Greg Brewer, Stacy M Endres-Dighe, Dylan Hampton, Mark T. Gladwin, Marion C. Lanteri, Thomas Raife, Sonia Bakkour, Karla Murcia, Grier P. Page, Mila Lebedeva, Val Rychka, Xiaoyun Fu, Tamir Kanias, Steve Kleinman, Michael P. Busch, Mars Stone, Derek Sinchar, Adam Jakub, Sheila M. Keating
Publikováno v:
Transfusion. 59:57-66
BACKGROUND The major aims of the RBC-Omics study were to evaluate the genomic and metabolomic determinants of spontaneous and stress-induced hemolysis during RBC storage. This study was unique in scale and design to allow evaluation of RBC donations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d273a87b2befce412d77275da75a1dc
https://doi.org/10.1111/trf.15099
https://doi.org/10.1111/trf.15099
Autor:
Philip J. Norris, Sherrill J. Slichter, Jar How Lee, Douglas Bolgiano, Rachael P. Jackman, Rui Pei, Mila Lebedeva
Publikováno v:
Transfusion. 56:1442-1450
BACKGROUND In the Trial to Reduce Alloimmunization to Platelets (TRAP) study, 101 of 530 subjects became clinically refractory (CR) to platelets (PLTs) without lymphocytotoxicity assay (LCA)-detectable anti-HLA antibodies. The LCA only detects comple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78ff243cc6757b6222cf723d8cafd95b
https://doi.org/10.1111/trf.13598
https://doi.org/10.1111/trf.13598
Autor:
Philip J, Norris, Zhanna, Kaidarova, Erica, Maiorana, Silvano, Milani, Mila, Lebedeva, Michael P, Busch, Brian, Custer, Paolo, Rebulla
Publikováno v:
Transfusion. 58(5)
The current study explored whether pathogen-reduction treatment of platelet components before transfusion would decrease the risk of alloimmunization.Study participants were patients with hematologic cancer who were included in two parallel, randomiz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6807c21150f8b553030abb30aae14884
https://pubmed.ncbi.nlm.nih.gov/29473173
https://pubmed.ncbi.nlm.nih.gov/29473173
Autor:
Dylan Hampton, Mohamed Abdel-Mohsen, Gary Murphy, Xutao Deng, Michael P. Busch, Steven G. Deeks, Satish K. Pillai, Alex Welte, Frederick Hecht, Vivek Jain, Christopher D. Pilcher, Mila Lebedeva, Sheila M. Keating, Shelley N. Facente
Publikováno v:
The Journal of infectious diseases, vol 216, iss 1
Background Human immunodeficiency virus (HIV) antibodies are generated and maintained by ongoing systemic expression of HIV antigen. We investigated whether HIV antibody responses as measured by high-throughput quantitative and qualitative assays cou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72385457230f4ab360aba2f11922e73f
https://escholarship.org/uc/item/7dk0h9hq
https://escholarship.org/uc/item/7dk0h9hq
Autor:
Esper G. Kallas, Reshma Kassanjee, Sheila M. Keating, Alex Welte, Mila Lebedeva, Jeffrey N. Martin, Jeffrey C. MacArthur, Eduard Grebe, Christopher D. Pilcher, Gary Murphy, Susan J. Little, Matthew Price, Shelley N. Facente, Michael P. Busch
Publikováno v:
Journal of acquired immune deficiency syndromes (1999), vol 73, iss 5
Journal of Acquired Immune Deficiency Syndromes (1999)
Journal of Acquired Immune Deficiency Syndromes (1999)
Objective HIV seroconversion biomarkers are being used in cross-sectional studies for HIV incidence estimation. Bio-Rad Geenius HIV-1/2 Supplemental Assay is an immunochromatographic single-use assay that measures antibodies (Ab) against multiple HIV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::382ecb8e77cf517ad86c5638080177f4
https://escholarship.org/uc/item/4sd978qp
https://escholarship.org/uc/item/4sd978qp
Autor:
Xutao Deng, Harvey Alter, Sherrill J. Slichter, Eva Operskalski, Mila Lebedeva, Philip J. Norris, Garth H. Utter, Cathy Schechterly, Rachael P. Jackman, Douglas Bolgiano, Michael P. Busch, Naomi L. Luban
Publikováno v:
Transfusion. 54:672-680
Background Both leukoreduction and ultraviolet (UV) light treatment of blood products have been shown to reduce the incidence of HLA antibody development in recipients, but the impact of these treatments on the magnitude and persistence of the antibo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbafcad01f7d381913edb23db9c0ea93
https://doi.org/10.1111/trf.12317
https://doi.org/10.1111/trf.12317
Autor:
Michael P. Busch, Sherry M. Owen, Richard D. Moore, N. L. Ali-Napo, Debra L. Hanson, Susan L. Stramer, Mila Lebedeva, Philip J. Norris, Sheila M. Keating, Oliver Laeyendecker
Publikováno v:
Journal of Clinical Microbiology. 50:3968-3976
Recent-infection testing assays/algorithms (RITAs) have been developed to exploit the titer and avidity of HIV antibody evolution following seroconversion for incidence estimation. The Vitros Anti-HIV 1+2 assay (Ortho-Clinical Diagnostics) was approv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a820cb12ece4df5f379925f8cf7eb18
https://doi.org/10.1128/jcm.01454-12
https://doi.org/10.1128/jcm.01454-12
Autor:
Rachael P, Jackman, Jar-How, Lee, Rui, Pei, Douglas, Bolgiano, Mila, Lebedeva, Sherrill J, Slichter, Philip J, Norris
Publikováno v:
Transfusion. 56(6)
In the Trial to Reduce Alloimmunization to Platelets (TRAP) study, 101 of 530 subjects became clinically refractory (CR) to platelets (PLTs) without lymphocytotoxicity assay (LCA)-detectable anti-HLA antibodies. The LCA only detects complement-bindin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9513503894e5b72f83834681862aa754
https://pubmed.ncbi.nlm.nih.gov/27079754
https://pubmed.ncbi.nlm.nih.gov/27079754
Autor:
Mila Lebedeva, Steven Kleinman, Danielle M. Carrick, Jerome L. Gottschall, Philip J. Norris, Jar-How Lee, Michael P. Busch, B R de Castro
Publikováno v:
Transfusion. 49:243-251
Background Human leukocyte antigen (HLA) antibodies are a possible cause of transfusion-related acute lung injury (TRALI), and fluorescent bead assays are often used for antibody detection. Serum is the manufacturer's recommended sample, but plasma m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9668624594dcac01d92f9af97b37266
https://doi.org/10.1111/j.1537-2995.2008.01955.x
https://doi.org/10.1111/j.1537-2995.2008.01955.x
Autor:
Rachael P, Jackman, Xutao, Deng, Douglas, Bolgiano, Garth H, Utter, Cathy, Schechterly, Mila, Lebedeva, Eva, Operskalski, Naomi L, Luban, Harvey, Alter, Michael P, Busch, Sherrill J, Slichter, Philip J, Norris
Publikováno v:
Transfusion. 54(3)
Both leukoreduction and ultraviolet (UV) light treatment of blood products have been shown to reduce the incidence of HLA antibody development in recipients, but the impact of these treatments on the magnitude and persistence of the antibody response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::57bc92e1d9853650c9458d6e82c0f230
https://pubmed.ncbi.nlm.nih.gov/23808544
https://pubmed.ncbi.nlm.nih.gov/23808544